Authors: SPIVAK B ROITMAN S VERED Y MESTER R GRAFF E TALMON Y GUY N GONEN N WEIZMAN A

Citation: B. Spivak et al., DIMINISHED SUICIDAL AND AGGRESSIVE-BEHAVIOR, HIGH PLASMA NOREPINEPHRINE LEVELS, AND SERUM TRIGLYCERIDE LEVELS IN CHRONIC NEUROLEPTIC-RESISTANT SCHIZOPHRENIC-PATIENTS MAINTAINED ON CLOZAPINE, Clinical neuropharmacology, 21(4), 1998, pp. 245-250

Authors: SPIVAK B ADLERSBERG S ROSEN L GONEN N MESTER R WEIZMAN A

Citation: B. Spivak et al., TRIHEXYPHENIDYL TREATMENT OF CLOZAPINE-INDUCED HYPERSALIVATION, International clinical psychopharmacology, 12(4), 1997, pp. 213-215

Authors: SPIVAK B MESTER R ABESGAUS J WITTENBERG N ADLERSBERG S GONEN N WEIZMAN A

Citation: B. Spivak et al., CLOZAPINE TREATMENT FOR NEUROLEPTIC-INDUCED TARDIVE-DYSKINESIA, PARKINSONISM, AND CHRONIC AKATHISIA IN SCHIZOPHRENIC-PATIENTS, The Journal of clinical psychiatry, 58(7), 1997, pp. 318-322

Authors: SPIVAK B GONEN N MESTER R AVERBUCH E ADLERSBERG S WEIZMAN A

Citation: B. Spivak et al., NEUROLEPTIC MALIGNANT SYNDROME-ASSOCIATED WITH ABRUPT WITHDRAWAL OF ANTICHOLINERGIC AGENTS, International clinical psychopharmacology, 11(3), 1996, pp. 207-209

Authors: MESTER R MENDEL A GONEN N BECKER D ADLESBERG S

Citation: R. Mester et al., PROBLEMS IN IMPLEMENTING THE 1991 TREATMENT OF MENTAL-PATIENTS LAW INISRAEL, Israel journal of psychiatry and related sciences, 32(2), 1995, pp. 102-107